Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.4990
-0.1609 (-24.38%)
At close: Mar 18, 2026

Clearside Biomedical Revenue

Clearside Biomedical had revenue of $201.00K in the quarter ending September 30, 2025, a decrease of -80.64%. This brings the company's revenue in the last twelve months to $3.33M, down -56.78% year-over-year. In the year 2024, Clearside Biomedical had annual revenue of $1.66M, down -79.77%.

Revenue (ttm)
3.33M
Revenue Growth
-56.78%
P/S Ratio
0.78
Revenue / Employee
104.03K
Employees
32
Market Cap
2.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.66M-6.56M-79.77%
Dec 31, 20238.23M6.90M519.89%
Dec 31, 20221.33M-28.25M-95.51%
Dec 31, 202129.58M21.68M274.65%
Dec 31, 20207.89M5.72M263.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
LakeShore Biopharma84.75M
Sorrento Therapeutics64.27M
Orgenesis899.00K
GPL Holdings376.54K
AXIM Biotechnologies92.90K
Revenue Rankings